# Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease

> **NCT04008810** · — · COMPLETED · sponsor: **Hillerod Hospital, Denmark** · enrollment: 1032 (actual)

## Conditions studied

- Chronic Kidney Diseases
- CKD
- NGAL
- Neutrophil Gelatinase-associated Lipocalin
- Emergency Department
- AKI
- Acute Kidney Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04008810
- **Lead sponsor:** Hillerod Hospital, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-03
- **Primary completion:** 2023-01-10
- **Final completion:** 2024-06-03
- **Target enrollment:** 1032 (ACTUAL)
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04008810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04008810, "Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04008810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*